New drug duo tested in Tough-to-Treat stomach and liver cancers
Disease control
Completed
This study tested whether combining two drugs, telatinib and Keytruda, could help control advanced stomach or liver cancers that had worsened after standard treatments. It involved 16 patients with these specific cancers. The main goal was to see how long the combination could ke…
Phase: PHASE2 • Sponsor: Andrew Hendifar, MD • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC